A Phase 2 trial of Resomelagon in Dengue Infection

Recruiting Phase 2 NCT06917001

Study Description

Evaluating the Safety and Effectiveness of Resomelagon in Treating Adult Patients with Dengue Virus Infection

Study Details

Registry ID:: NCT06917001
Conditions:: Dengue Fever
Phase:: Phase 2
Target Enrollment:: 120 participants
Start Date:: March 20, 2026
Age Range:: 18–65 years
Healthy Volunteers:: No

Study Locations (3 sites)

Clinical Research Unit
Belo Horizonte, MGBrazil, Brazil
Clinical Research Unit
Belo Horizonte, Minas GeraisBrazil, Brazil
Centro Integrado de Pesquisa
São José do Rio Preto, São PauloBrazil, Brazil

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →